SCHEMBL25051145

SCHEMBL25051145

CC1CN(C(C)(C)C)CCN1C(C)(C)CCC(C)(C)N1CCCN(C(C)(C)C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24735068 0.95
SCHEMBL22062797 0.85
SCHEMBL25533579 0.83
SCHEMBL19134722 0.80
SCHEMBL24330287 0.78
SCHEMBL19491922 0.78
SCHEMBL24735051 0.77
SCHEMBL25565027 0.76
SCHEMBL24735387 0.75 CHRM2 (0.31)
SCHEMBL25726171 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047626-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY 2023-02-16 US disclosed